Company intelligence / Profile preview

Celergen Swiss

Zug, Switzerland

Ownership: Private
Development stage: Other

Overview

Celergen is a Swiss-based nutraceutical company specializing in anti-aging and regenerative wellness products. Its flagship product, Celergen, is marketed as a "Swiss Cold Processed Marine Cell Therapy" supplement derived from deep-sea marine life. The company focuses on cellular rejuvenation, claiming benefits for skin health, joint mobility, energy levels, and overall vitality. Celergen utilizes a proprietary cold extraction technology to maintain the bioactivity of its marine DNA and peptide components. The brand is positioned in the luxury wellness and anti-aging market globally, distributed through a network of healthcare professionals and specialized wellness centers.

Therapeutic areas: DermatologyRheumatologyOther
Modalities: PeptidesNutritional Supplement
Industry: Food & Nutrition

Beyond the preview

Go deeper on Celergen Swiss.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celergen Swiss.

Explore the full profile